Opdivo Could Boost Outcomes for People Battling Hodgkin Lymphoma

TUESDAY, July 6, 2023 -- The widely used immunotherapy drug nivolumab (Opdivo) is safer and more effective in treating adults and children with advanced Hodgkin lymphoma than the targeted therapy now used as standard care is, new clinical trial...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news